| Daniel R Harrah, MD | |
|
3220 Hospital Dr, Juneau, AK 99801-7808 | |
| (907) 364-2663 | |
| (907) 364-2662 |
| Full Name | Daniel R Harrah |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 31 Years |
| Location | 3220 Hospital Dr, Juneau, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053339325 | NPI | - | NPPES |
| MD43472 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 5018 (Alaska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Juneau Bone And Joint Center Llc | 7214038157 | 8 |
News Archive
Statins are prescribed to millions of people worldwide to reduce their risks of suffering heart attacks and strokes.
A new study from researchers at Johns Hopkins Bloomberg School of Public Health and colleagues suggests a slowdown in the use of convalescent plasma to treat hospitalized COVID-19 patients led to a higher COVID-19 mortality during a critical period during this past winter's surge.
Cell Therapeutics, Inc. today announced that the University of Washington has begun enrolling patients in a randomized phase II study testing the combination of tosedostat with either cytarabine or decitabine for elderly patients with newly-diagnosed acute myeloid leukemia ("AML") or high-risk myelodysplastic syndrome.
RBC Life Sciences, Inc., a provider of proprietary nutritional supplements, wound care and pain management products, today reported company-wide net sales of $7.8 million for the second quarter ended June 30, 2010, compared to net sales of $6.8 million for the same period during 2009, an increase of 16%. Net sales for the six months ended June 30, 2010 also increased 16% to $14.8 million compared to net sales of $12.8 million during the same period in 2009.
› Verified 6 days ago
| Entity Name | Juneau Bone & Joint Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699808139 PECOS PAC ID: 7214038157 Enrollment ID: O20070723000569 |
News Archive
Statins are prescribed to millions of people worldwide to reduce their risks of suffering heart attacks and strokes.
A new study from researchers at Johns Hopkins Bloomberg School of Public Health and colleagues suggests a slowdown in the use of convalescent plasma to treat hospitalized COVID-19 patients led to a higher COVID-19 mortality during a critical period during this past winter's surge.
Cell Therapeutics, Inc. today announced that the University of Washington has begun enrolling patients in a randomized phase II study testing the combination of tosedostat with either cytarabine or decitabine for elderly patients with newly-diagnosed acute myeloid leukemia ("AML") or high-risk myelodysplastic syndrome.
RBC Life Sciences, Inc., a provider of proprietary nutritional supplements, wound care and pain management products, today reported company-wide net sales of $7.8 million for the second quarter ended June 30, 2010, compared to net sales of $6.8 million for the same period during 2009, an increase of 16%. Net sales for the six months ended June 30, 2010 also increased 16% to $14.8 million compared to net sales of $12.8 million during the same period in 2009.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel R Harrah, MD 3220 Hospital Dr, Juneau, AK 99801-7808 Ph: (907) 364-2663 | Daniel R Harrah, MD 3220 Hospital Dr, Juneau, AK 99801-7808 Ph: (907) 364-2663 |
News Archive
Statins are prescribed to millions of people worldwide to reduce their risks of suffering heart attacks and strokes.
A new study from researchers at Johns Hopkins Bloomberg School of Public Health and colleagues suggests a slowdown in the use of convalescent plasma to treat hospitalized COVID-19 patients led to a higher COVID-19 mortality during a critical period during this past winter's surge.
Cell Therapeutics, Inc. today announced that the University of Washington has begun enrolling patients in a randomized phase II study testing the combination of tosedostat with either cytarabine or decitabine for elderly patients with newly-diagnosed acute myeloid leukemia ("AML") or high-risk myelodysplastic syndrome.
RBC Life Sciences, Inc., a provider of proprietary nutritional supplements, wound care and pain management products, today reported company-wide net sales of $7.8 million for the second quarter ended June 30, 2010, compared to net sales of $6.8 million for the same period during 2009, an increase of 16%. Net sales for the six months ended June 30, 2010 also increased 16% to $14.8 million compared to net sales of $12.8 million during the same period in 2009.
› Verified 6 days ago
Gordon R. Bozarth, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3220 Hospital Dr, Juneau, AK 99801 Phone: 907-364-2663 Fax: 907-364-2662 | |
Dr. Jon A Reiswig, MD, Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 11260 N Douglas Hwy, Juneau, AK 99801 Phone: 907-586-3821 Fax: 907-463-2642 | |
Ted Lewis Schwarting, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3260 Hospital Dr, Juneau, AK 99801 Phone: 907-796-8631 Fax: 907-796-8455 | |
Alan S. Gross, Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3220 Hospital Dr, Juneau, AK 99801 Phone: 907-364-2663 Fax: 907-364-2662 |